# Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

> **NCT00045513** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto**

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** 7-hydroxystaurosporine
- **DRUG:** fludarabine phosphate

## Key facts

- **NCT ID:** NCT00045513
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2003-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045513, "Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00045513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*